Table 6.
α [Gy-1] | α/β [Gy] | γ50 | Det. rate PET [%] | Dose [Gy] | SIB [Gy] | Single dose [Gy] | TCPconv [%] | TCP Increase [%] |
---|---|---|---|---|---|---|---|---|
0.04 | 1.5 | 2.2 | 81 | 78 | 90 | 2 | 77.2 | 14.9 |
0.04 | 1.5 | 2.2 | 64 | 78 | 90 | 2 | 77.2 | 11.5 |
0.06 | 3.1 | 2.2 | 81 | 78 | 90 | 2 | 77.2 | 14.1 |
0.06 | 3.1 | 2.2 | 64 | 78 | 90 | 2 | 77.2 | 11.0 |
0.08 | 8.3 | 2.2 | 81 | 78 | 90 | 2 | 77.2 | 13.1 |
0.08 | 8.3 | 2.2 | 64 | 78 | 90 | 2 | 77.2 | 10.1 |
Calculation of the TCP-increase after boosting choline PET positive regions within the prostate up to 90 Gy, higher homogeneous whole prostate dose. α/β was analytically determined in order to achieve agreement between calculated TCD50 and TCD50 obtained by Cheung et al. γ50 was again taken from Cheung's data (ASTRO definition).